Filetype
Studies from our and other laboratories have over the last 2 years implicated the existence of multipotent progenitors (MPPs) with combined granulocyte-macrophage, B cell, and T cell potential, but little or no megakaryocyte-erythroid (MkE) potential in the adult bone marrow Lineage (-)SCA-1 +KIT+ (LSK) compartment of multipotent stem and progenitor cells. The evidence for the existence of LSKCD34
A hierarchical multi-scale model that couples a region of material described by discrete dislocation plasticity to a surrounding region described by conventional crystal plasticity is presented. The coupled model is aimed at capturing non-classical plasticity effects such as the long-range stresses associated with a density of geometrically necessary dislocations and source limited plasticity, whi
This article examines the introduction of the Balanced Scorecard (BSC) among municipalities in Sweden from a diffusion perspective. The point of departure in the article is that there is a gap in our understanding concerning the diffusion of new management accounting constructs. Over the last decade, research has largely been based on empirical evidence regarding early adopters. Furthermore, these
The industrial involvement in Open Source Software projects is increasing. More and more companies are turning their proprietary code into open source, contribute actively to the development of Open Source Software projects or/and use Open Source Software products as (part of) their own products. Software Configuration Management provides the infrastructure that is the foundation for any type of s
We hypothesized that key signaling pathways of glioma genesis might enable the molecular classification of gliomas. Gene coexpression modules around epidermal growth factor receptor (EGFR) (EM, 29 genes) or platelet derived growth factor receptor A (PDGFRA) (PM, 40 genes) in gliomas were identified. Based on EM and PM expression signatures, nonnegative matrix factorization reproducibly clustered 1
Identification of novel biomarkers for early diagnosis, prognosis, and treatment decision will be instrumental for improving disease outcome for patients suffering from complex diseases, such as cancer and autoimmune disorders. Within personalized medicine, the use of circulating biomarkers will allow clinicians to tailor medical treatment based on individual characteristics of each patient, using
